(Q36642702)

15 August 2017

1 reference

title

Targeting angiogenesis versus myogenesis with cardiac cell therapy (English)

1 reference

15 August 2017

2

Noel M Caplice

1 reference

15 August 2017

Brendan Doyle

1

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Cardiovascular Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

745-753

1 reference

Cardiac stem cells and mechanisms of myocardial regeneration

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Angiogenesis: where do we stand now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Structural basis of end-stage failure in ischemic cardiomyopathy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

PKC-alpha regulates cardiac contractility and propensity toward heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Ventricular myocytes are not terminally differentiated in the adult mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Evidence that human cardiac myocytes divide after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Myocyte proliferation in end-stage cardiac failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Mesenchymal stem cells and their potential as cardiac therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Early expression of angiogenesis factors in acute myocardial ischemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Clinical applications of stem cells for the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Cellular transplantation: hurdles remaining before widespread clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Cell therapy for cardiovascular disease: what cells, what diseases and for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Monitoring of bone marrow cell homing into the infarcted human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Iron oxide MR contrast agents for molecular and cellular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.5.745

21 January 2018

Identifiers

DOI

10.1586/14779072.4.5.745

1 reference

15 August 2017

1 reference